Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

EDX.L

STRONG SELL

EDX Medical Group Plc · Healthcare · United Kingdom · $65M · Avg Vol: $8K/d

6
StockRank
Get insider-trade alerts
Q
26
V
25
M
25
P/E (TTM)
—
ROE
—
D/E
—
Dividend %
—
Dir. Trades · 180d
None →
Buybacks · 180d
None →

COMPANY DESCRIPTION

EDX Medical Group Plc develops and commercializes innovative digital diagnostic products and services to enable personalized medicine for cancer, heart disease, and infectious diseases. The company's competitive moat is built on its strategic partnerships with leading academic institutions and its proprietary biomarker validation platforms. EDX Medical operates as a niche diagnostics player focused on translating advanced clinical research into cost-effective, point-of-care testing solutions.

Loading 1Y...
PRICE (1Y)+18.4%
0.110.120.130.140.15Jun 15Jul 6Jul 24
SMA 50SMA 200
Close
$0.1485

SCORE BREAKDOWN

Quality
26
ROIC (ROA)
—N/A
ROE
—N/A
GP/Assets
—N/A
Op. Margin
0.0%41.3
FCF/Assets
—N/A
Piotroski
0N/A
Int. Cover
—N/A
D/E Ratio
—N/A
Current Ratio
—N/A
Value
25
P/E (TTM)
—N/A
EV/EBITDA
—N/A
P/FCF
—N/A
P/B
—N/A
P/S
—N/A
Div Yield
—N/A
Momentum
25
52W High %
—N/A
RS 6M
—N/A
SMA 50/200
—N/A
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$65M
P/E (Forward)
—
Gross Margin
—

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of EDX.L are excluded.

TickerCompanyMkt CapStockRankSignal
EDX.LEDX Medical Group Plc(you)$65M6STRONG SELL
CLBX.LCelLBxHealth plc$39M16STRONG SELL
GDR.Lgenedrive plc$28M16STRONG SELL
HVO.LhVIVO plc$63M36HOLD
ABDX.LAbingdon Health Plc$34M41HOLD
HEMO.LHemogenyx Pharmaceuticals Plc$70M9STRONG SELL
OKYOOKYO Pharma Limited$81M6STRONG SELL
MREOMereo BioPharma Group plc$50M6STRONG SELL
4BB.L4basebio PLC$110M11STRONG SELL
TLSATiziana Life Sciences Ltd$114M1STRONG SELL

Peer medians: ROE -1.8% · P/E 24.7x · Gross margin 56.3%

EDX Medical Group Plc (EDX.L) — Stock Score Summary

EDX Medical Group Plc (EDX.L) has a MoatMap StockRank of 6/100 based on Quality (26/100), Value (25/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL.

EDX Medical Group Plc develops and commercializes innovative digital diagnostic products and services to enable personalized medicine for cancer, heart disease, and infectious diseases. The company's competitive moat is built on its strategic partnerships with leading academic institutions and its proprietary biomarker validation platforms. EDX Medical operates as a niche diagnostics player focused on translating advanced clinical research into cost-effective, point-of-care testing solutions.

Key Financial Metrics

Price$0.15
Market Cap$65M
Operating Margin0.0%

EDX Medical Group Plc operates in the Diagnostics & Research industry, part of the Healthcare sector (United Kingdom).

Frequently Asked Questions

What is EDX Medical Group Plc’s (EDX.L) StockRank?
MoatMap’s StockRank for EDX Medical Group Plc (EDX.L) is 6/100, with a Strong Sell signal. It is a composite of Quality (26), Value (25), and Momentum (25) factor ranks across MoatMap’s 20,000+ stock universe.
Does EDX Medical Group Plc have an economic moat?
EDX Medical Group Plc (EDX.L) has a Quality factor score of 26/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is EDX Medical Group Plc a buy, hold, or sell?
MoatMap’s current signal for EDX Medical Group Plc (EDX.L) is Strong Sell, based on a StockRank of 6/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is EDX Medical Group Plc in?
EDX Medical Group Plc (EDX.L) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United Kingdom).
Browse all ranked stocksEDX.L deep dive reportAI ChampionsHow we score stocksSense-check another stock